ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis. Issue 18 (30th September 2022)

• Record Type: Journal Article
• Authors: Jiang, Kai; Chen, Haiyan; Ding, Kefeng
• Is Part Of: Clinical science. Volume 136:Issue 18(2022)
• Page Start: 1367
• Page End: 1370
• Publication Date: 2022-09-30
• Subjects: ANGPTL1 -- colorectal cancer -- Foxo3a -- metastasis -- Sox2; Medicine -- Periodicals; Biochemistry -- Periodicals; 616
• DOI: 10.1042/CS20220394
• Languages: English
• ISSNs: 0143-5221

Abstract

Abstract: In the present commentary, we discuss new observations stating that angiopoietin-like protein 1 (ANGPTL1) attenuates cancer metastasis and stemness through Forkhead box O-3a (Foxo3a)–SRY-related HMG-box-2 (Sox2) axis in colorectal cancer ( Clin. Sci . (2022) 136, 657–673, https://doi.org/10.1042/CS20220043 ). ANGPTL1 has been reported to play a critical role in cancer progression and metastasis. However, the underlying mechanisms remain controversial. Here, we integrate the possible mechanisms for ANGPTL1 inhibiting colorectal cancer liver metastasis and discuss the regulation of ANGPTL1 on the Foxo3a–Sox2 pathway. Although ANGPTL1 showed multifunctional potential, there is still a long way to go for ANGPTL1 to be an effective treatment strategy in the clinic.